Laboratory Medicine 2007: Vol 38 Index & Table of Contents

2007·4.5 MB·English

Annual Index
Subject Index Program, Jan 13, Feb 69, April 204, June 335, April 249; multiplex antinuclear antibody
A Aug 454, 455, Sept 519; chemical emergen- assay in pediatric patients, Nov 671
Abadie, Jude: joins LABMEDICINE Editorial Advisory Cies survey, “sb &1- collaboration with ASCLS, Anti-rejection therapy: flow cytometry for monitor-
Board, Nov 646 April 201, Sept 521; cytciogy assessment pro- ing, July 433
Accountability, Sept 576 grams, June 328; on direct billing, Aug 459; Anti-smooth muscle antibodies: in autcimmune hep-
eCourses, Feb 75, March 149, Aug 460; 85th atitis, April 249
Accreditation: to ISO 1518S standard, May 279;
anniversary of, May 261; on electronic med- Antithrombin: laboratory monitoring of heparin, Aug
JCAHO unannounced surveys, Jan 8; readi-
ness for unannounced assessments, April 217 ical records, July 393; “Fix the Law” cam- 499; tube filling order's effect on specific
Acquired immunodeficiency syndrome (AIDS): in paign in New York State, May 265, July 395, coagulation parameters in healthy subjects,
Aug 460; Guyana outreach of, July 392; GYN Sept 556
Guyana, July 392. See also Human immunod-
PT, Feb 69, April 200, June 336; health infor- Apheresis: and cytomegalovirus DNA levels in sam-
eficiency viruses (HIV)
mation technology policy adopted, July 396; ples, Nov 676
Activated partial thromboplastin time (APTT): labora-
international certification offered, June 326, Arginine vasopressin (antidiuretic hormone): in kid-
tory monitoring of heparin, Aug 499; tube fill-
330, Aug 457, Sept 519; laboratory training ney function, May 297
ing order's effect on specific coagulation
programs in Africa, Feb 68, June 335, Aug Armed Forces Institute of Pathology (AFIP), March
parameters in healthy subjects, Sept 556
457; Leadership Exchange, Jan 6, Feb 72, 139, June 332
ADAMTS13: in thrombotic thrombocytopenic purpu-
March 137, 149, May 267, 268; in legislative Arneson, Wendy: in African laboratory training pro-
ra/hemolytic uremic syndrome, Oct 611
symposium, March 137, June 332; Master grams, Feb 68
Adenocarcinoma: of the colon, giant myelolipoma of
membership category inuwouuced, Jan 15, Feb Arthraigias’ and hyperuricemia during pyrazinamide
the adrenal gland with, Aug 491
69, 71, April 200; Medical Technology Today therapy in patients with pulmonary tuberculo-
Adrenal glands: giant myelolipoma of, with adeno-
newsmagazine, Sept 525; Member awards sis, Aug 495
carcinoma of the colon, Aug 491
presented by, March 136, 137; National ASCP Institute, Feb 69, Sept 519
Aedes aegypti: dengue fever caused by, Jan 24
Student Honor Award, Feb 75, Aug 458; as Askwith, Bethany: on LabQ, April 204
Africa: laboratory training programs in, Feb 68, June
pathology society of “firsts,” Oct 595; patient Assessinent: in teaching research design and prac-
335, Aug 457
Agar: in yeast identification, March 180, 181 safety policy, Jan 7; “pod” laboratories cam- tice, Oct 585
paign, March 135, April 203, June 331, Aug Asthma: total and specific IgE in sera of patients
AIDS. See Acquired immunodeficiency syndrome
(AIDS) 459, Sept 519, 523; qualification in laboratory with, Oct 621
Albumin: albuminuria in disease detection, Jan 35; informatics, March 134; Student Scholarships Austin, R Marshall: on Pap testing, April 198
2006-2007, May 264; teleconferences, March Autoimmune disorders: differential diagnosis of
as nutritional status marker, Jan 45
149; Workshops for Laboratory Professionals, Wegener's granulomatosis from other small
Albuminuria: in disease detection, Jan 35
March 149 vessel vasculitides, July 437; hepatitis, April
Aldosterone: immunocomplex substitution reaction
Amyloidosis, cardiac, secondary to multiple myelo- 248; multiplex antinuclear antibody assay in
in radioimmunoassay of, Jan 29
ma, Sept 543 pediatric patients, Nov 671
Alexander, Tom: in African laboratory training pro-
Analysis of Variance (ANOVA), Oct 583 Automation: of gynecologic cytology, May 269; of
grams, Feb 68
Anatomic pathology: Lean projects for, Jan 10 histology laboratory, July 405; in molecular
Algorithms: image-analysis, June 343; in yeast iden-
Anemia: in hemoglobin E disease, Sept 539; in diagnostics, Aug 475
tification, March 180
hemoglobin H disease, April 222; iron defi- Avian influenza A (H5N1): pandemic potential and role
Alkaline phosphatases: as biological markers of
ciency diagnosis in infants, Feb 103 of clinical microbiology laboratory, Dec 740
bone metabolism, May 276
Allergies: flow cytometry in diagnosis of, July 434; Ann Arbor classification system: for non-Hodgkin's B
laboratory testing to identify individuals with lymphoma, April 244 Babesiosis: case study of, May 282
inhalant, Nov 649; specific IgE testing, Jan 17; ANOVA (Analysis of Variance), Oct 583 Bacteria: continuous ambulatory peritoneal dialysis-
total and specific IgE in diagnosis of, Oct 621 Anthroconidia, March 182 associated peritonitis involving Neisseria
American Association of Blood Banks (AABB): Antibodies: anti-neutrophil cytoplasmic antibodies in sicca/subflava, June 363; Fusobacterium
CMoodmem!e nQduaalbiltey SPyrsatcetimc eosf ,f iMlae yo f,2 7D9e c 713; Wceytgoemneetrr'ys fgorr aHnuLlAo maaltloosainst,i boJduyl y de4t3e1c;t ifolno,w July Jnuelcyr o4p2h0o;r uumlt,r avJiuollye t 41l4a;m pM omroanxietlolrai ngca tianr rbhiaol-i s,
433. See also Antinuclear antibodies;
American Hospital Association (AHA), July 395 logical safety cabinets with cultures of stan-
American Journal of Clinical Pathology, Oct 598 Monocional antibodies dard strains of, March 165; Vibrio in the
American Medical Association (AMA): annual advo- Anticoagulants: laboratory monitoring of heparin, United States, Nov 688
cacy conference, May 265; Physician Aug 499; mixing procedures for K2 EDTA pri- Bacterial artificial chromosomes, Sept 528, 533
Consortium for Performance improvement, Jan mary samples’ effects on hematological sam- Bailey, James H: Regional Member Award for, May
12 ples, Dec 723 267
American National Standards Institute (ANSI), Sept Antidiuretic hormone (arginine vasopressin): in kid- Ball, John R: on innovation, Feb 70
519 ney function, May 297 Bar coding: ISBT 128 and, April 214
American Proficiency institute (API), April 237 Anti-D method: for fetomaternal hemorrhage detec- Baseline viral load: as hepatitis C virus predictor of
American Society for Clinical Laboratory Science tion, June 366 treatment outcome, Feb 88
(ASCLS): Annual Meeting, April 202; collabora- Anti-factor Xa activity assay: laboratory monitoring Basophilic stippling, fine: in babesiosis patient, May
tion with ASCP, April 201, Sept 521; at legisla- of heparin, Aug 499 282
tive symposium 2007, March 137, 139, June Antifungal susceptibility testing: flow cytometry in, BCR/ABL fusion gene: in myeloproliferative disor-
332 July 434 ders, Feb 109
American Society for Clinical Pathology (ASCP): in Antigens: flow cytometry for assessing specific, July Benchmarks: establishment of, Dec 709
American Medical Association Physician 431; in yeast identification, March 180 Bennett, Andrea T: joins ASCP Washington staff, Feb
Consortium for Performance Improvement, Jan Anti-HbF monocional antibodies: for fetomaternal 74
12; Annual Meeting in New Orleans, May 262, hemorrhage detection, June 366 Berte, Lucia M: on nonconforming laboratory event
Sept 524; Board of Director nominations, Jan Anti-kidney-liver-microsomal antibodies: in autoim- management, Sept 537
13; Board of Registry accredited by ANSI, May mune hepatitis, April 249 Best, Michele: leaves LABMEDICINE Editorial
262; Board of Registry research 1993-2007, Anti-neutrophil cytoplasmic antibodies: in Wegener's Advisory Board, Nov 646
an annotated bibliography, Oct 587; CCCLW granulomatosis, July 431 Beta trace protein: as renal function marker, May
meets at, May 264; Certification Maintenance Antinuclear antibodies: in autoimmune hepatitis, 301
Dec2e007 m®V oblumee 38r Num ber 12 #L ABMEDICINE 755
labmedicine.com
Annual Index
Bethesda Units, April 221 Cc CEBP gene activation by /GH@, Sept 531
Bilirubin: in thrombotic thrombocytopenic CA 19-9 elevation, Aug 485 Cell clonality: flow cytometric assessment of T-cell
purpura/hemolytic uremic syndrome, Oct 610 Calcofluor white: “Test Your Knowledge,” Dec 749; clonality in clinical specimens, Aug 477
Billing: CMS proposals on abuses by “pod” laborato- Torulopsis (Candida) glabrata and Candida Cell surface antigens: in multiparametric flow cyto-
ries, Jan 11, Feb 73 krusei identification using, April 227; in yeast metric diagnosis of myelodysplastic syn-
Biological safety cabinets: ultraviolet lamp monitor- - identification, March 180 dromes and related disorders, May 305
ing in, with cultures of standard bacterial Caldwell, Barbara: on ASCP Certification Cell-VU chambers: for sperm counting, April 232
strains, March 165 Maintenance Program, Jan 13 Centers for Medicare and Medicaid Services (CMS)
Biomarkers: basics of osteoporosis and use of bone Calibration: for preventing proficiency testing fail- competitive bidding project, Feb 73, April 204,
markers, May 273; of iron status, Feb 103; ures, March 185, 186 June 327; cytology proficiency testing reguia-
waist circumference and biomarkers for dia- California: MT(ASCP) certification approved for licen- tions, May 265; Medically Unbelievable Edits
betes and cardiovascular disease in healthy sure by, Jan 15 (MUE) proposal, March 135, June 331;
non-obese women, July 422. See also Cardiac Candida: medically-important yeasts, March 178; Physician Fee Schedule, March 139, Sept 523;
markers; Tumor markers “Test Your Knowledge,” Dec 749 “pod” laboratory proposal, Jan 11, Feb 73,
Candida albicans: medically-important yeasts, March 135, Aug 459
Bird flu. See Avian influenza A (H5N1)
March 178 Centrifuging: effect on stat clinical chemistry testing,
Birth iron indicators, Feb 106
Candida dubliniensis: medically-important yeasts, March 172
Black water fever, March 155 March 179 Certification: ASCP-ASCLS collaboration on, Sept
Bladder cancer: screening and future directions for Candida glabrata: identification using calcofluor 521; ASCP Board of Registry established, Oct
urine-based markers for bladder urothelial white, April 227; medically-important yeasts, 597; ASCP Board of Registry research
carcinoma, Feb 116; urine cytology and com- March 179 1993-2007, an annotated bibliography, Oct
mercially available urine-based markers for Candida krusei: identification using caicofluor white, 591; Certification Maintenance Program, Jan
monitoring bladder urothelial carcinoma, Jan April 227 13, Feb 69, April 204, June 335, Aug 454,
48 Carcinoembryonic antigen test: falsely elevated 455, Sept 519; fraudulent credentials and
Bladder tumor antigen tests: for monitoring bladder results in, Aug 498 importance of verifying, March 138; interna-
urothelial carcinoma, Jan 49 Cardiac markers: chemiluminescent assay for tional, June 326, 330, Aug 457, Sept 519
Blastoconidia, March 182 choline analysis in human plasma and whole Cervical cancer: dawn of new era of screening and
Biastoschizomyces capitatus: medically-important blood, Dec 726 prevention of, May 260; rejected and unsatis-
yeasts, March 179 Cardiovascular disease: albuminuria as risk factor factory specimens from liquid-based
BLCA-1: as bladder cancer tumor marker, Feb 117 for, Jan 35; waist circumference and biomark- (SurePath) preparations and conventional Pap
BLCA-4: as bladder cancer tumor marker, Feb 117 ers for, in healthy non-obese women, July 422 smears for cervicovaginal screening, Dec 729
Blood banking: ISBT 128, April 213; new guidelines Career development: ASCP Board of Registry “Chair's Message, ASCP Member Council”: “ASCP
to prevent HCV transmission, July 395; 2006 research 1993-2007, an annotated bibliogra- Expands International Activities,” Aug 457
annual survey of medical laboratory science phy, Oct 587. See also Education “Changes Enhance Reputation, Membership
programs, Aug 463 Caribbean Epidemiology Centre, July 392 Value,” Feb 71; “Electronic Medical Records,”
Blood collection: mixing procedures for K2 EDTA pri- Carollo, Tami: on ASCP qualification in laboratory July 393; “important March Events,” March
mary samples’ effects on hematological sam- informatics, March 141 137; “The Look of Success,” Sept 521; “More
ples, Dec 723; tube filling order's effect on Carter, Carla: on CLSI’s The Key to Quality, June 376 Strategies for Addressing Personnel
specific coagulation parameters in healthy Case studies: babesiosis, May 282; CA 19-9 eleva- Shortages,” June 329; “Singing Our Own
subjects, Sept 556. See a/so Phlebotomy tion, Aug 485; cardiac amyloidosis secondary Song,” Jan 9; “Smart Planning for the Future,”
Blood cultures: guidelines and standards for, Oct to multiple myeloma, Sept 543; cryoglobuline- May 263; “What Makes ASCP and ASCLS
mia, June 347; dengue fever, Jan 23; dissemi- Tick?”, April 201
603
nated histoplasmosis, June 352, July 416; Chamberlain, Anne: and JCAHO unannounced sur-
Blood glucose tests: requisition errors for, Sept 559
enterobiasis, June 357; false-positive creati- veys, Jan 8
Blood transfusion. See Transfusion medicine
nine value due to nitromethane ingestion, Dec Charcot Leyde. crystals: chronic myelomonocytic
Blood vessels: differential diagnosis of Wegener's 717; false-positive urine pregnancy testing in leukemia associated with, Feb 100
granulomatosis from other small vessel vas- women with cancer, May 280; hemoglobin E Chemical emergencies: chemical terrorism, Feb 81;
culitides, July 437 disease, Sept 539; hemoglobin H disease, eCourses on, Feb 75
Body mass index: in risk assessment for diabetes April 222; hemophilia B, April 218; hyperzin- Chemical terrorism, Feb 81
and cardiovascular disease, July 422 curia, Oct 608; Lemierre s syndrome, July Chemical warfare agents, Feb 83
Bone: basics of osteoporosis and use of bone mark- 413; malaria, March 153; malignant hyper- Chemiluminescence: assay for choline analysis in
ers, May 273 thermia, Feb 94; methemoglobinemia, Nov human plasma and whole blood, Dec 726
Bone alkaline phosphatase: as biological marker of 663; myelokathexis, Sept 549; neuromyelitis Chemistry: centrifugation time’s effect on stat test-
bone metabolism, May 276 optica, Oct 605; possible transfusion reaction ing, March 172; and ISBT 128, April 214; pro-
Bone markers: basics of osteoporosis and use of with positive direct antiglobulin test, Dec 719; ficiency testing performance in physician's
May 273 primary effusion lymphoma, March 150: Office, clinic, and small hospital laboratories,
Bone marrow aspiration: in non-Hodgkin's lym- thrombotic thrombocytopenic 1994-2004, April 237; “Test Your Knowledge,”
phoma diagnosis, April 245 purpura/hemolytic uremic syndrome, Oct 610 June 375
Bone mineral density: in osteoporosis, May 275 Zygomycetes in patient with systemic lupus Children: iron deficiency diagnosis in infants, Feb
Bone remodeling, May 274 erythematosus, Aug 487 103; multiplex antinuclear antibody assay in
Bonfiglio, Thomas A: American Society of Case study rubrics, Oct 584 Nov 671
Cytopathology President's Award for, Jan 12 Castellani, William: on Laboratory Instrument Chiamydospore, March 182
and ASCP and cytology proficiency testing Implementation, Verification, and Maintenance; Cholera: Vibrio in the United States, Nov 688
April 200 Proposed Guideline (GP31-P), Dec 715 Choline: chemiluminescent assay for analysis in
Bordetella pertussis: state public health laboratories Catheter-related bloodstream infections: guidelines human plasma and whole blood, Dec 726
surveyed for pertussis diagnostics, March 169 for diagnosing, Oct 604 CHROMagar, March 180
Brain: radiation necrosis of, March 157 Causal factor charting, Dec 710 Chromatography: affinity, hepatoma-specific GGT
Cavagnaro, Marian: in African laboratory training detection by, March 160. See also High-per-
Break-even point, April 207
programs, Feb 68 formance liquid chromatography (HPLC)
Breast cancer: FDA approves genetic test for recur-
CD4: H42-A2 guidelines on CD4+ subset counting, Chromosomal abnormalities: cytogenetics in myelo-
rence of, May 265
Nov 661; in primary effusion lymphoma proliferative disorders, Feb 110; molecular
Brooks, John SJ: at AMA annual advocacy confer-
March 150 cytogenetics in study of leukemia genome,
ence, May 265; on ASCP Master membership CD7: in primary effusion lymphoma, March 150 Sept 528
Category, Jan 15; in Medscape videotorial CD30: in primary effusion lymphoma, March 150 Chromosome 21: intrachromosomal ampiification of,
June 334; on New York State licensure law CD34: flow cytometry for enumeration of CD34+ in acute lymphoblastic leukemia, Sept 530
May 266; on “pod” laboratories, Feb 73, Aug stem and progenitor cells, July 433, Nov 661 Chromosome painting, Sept 528, 533
459 Cease, E Susan: to be installed as ASCP Member Churg-Strauss syndrome: Wegener's granulomatosis
Bypassing agents, April 221 Council chair, Sept 520 distinguished from, July 438
756 LABMEDICINE # Volume 38 Number 12 # Decembe20r0 7 labmedicine cor
Annual Index
Clinical and Laboratory Standards Institute (CLSI): using flow cytometry, June 365; laboratory fetal lung maturity testing in diabetic mothers,
blood culture guidelines, Oct 603; Clinical monitoring of heparin, Aug 499; multiparamet- Sept 553; iron status at birth and maternal,
Flow Cytometric Analysis of Neoplastic ric flow cytometry in diagnosis of myelodys- Feb 105; requisition errors for blood glucose
Hematolymphoid Cells; Approved Guideline— plastic syndromes and related disorders, May tests, Sept 559; 3’UTR polymorphism of IL12B
Second Edition (H43-A2), Nov 662; 305; placental examination, Oct 624; profi- in relation to susceptibility and development of
Enumeration of Immunologically Defined Cell ciency testing, March 184; urine cytology and type 1, May 289; waist circumference and
Populations by Flow Cytometry; Approved commercially available urine-based markers biomarkers for, in healthy non-obese women,
Guideline—Second Edition (H42-A2), Nov 661; for monitoring bladder urothelial carcinoma, July 422 .
The Key to Quality, June 376; Laboratory Jan 48; Vibrio in the United States, Nov 688 Diagnosis-related groups, July 395
Instrument Implementation, Verification, and Coordinating Council for the Clinical Laboratory Dialysis: continuous ambulatory peritoneal dialysis-
Maintenance; Proposed Guideline (GP31-P), Workforce (CCCLW), Jan 9, Feb 78, May 264, associated peritonitis involving Neisseria
Dec 715; Management of Nonconforming June 329 sicca/subflava, June 363; lithium self-intoxi-
Laboratory Events (HS12-P), April 217; Counahan-Barratt formula, May 301 cation treated with, Nov 667; in renal disease
Management of Nonconforming Laboratory Coverslipping: automation and, July 407 treatment, May 303
Events; Proposed Guideline (GP32-P), Sept Creatinine: false-positive value due to nitromethane Dieterich, Mark: at “Ask the Expert Day” school pro-
537 ingestion, Dec 717 gram, June 333
Clinical Flow Cytometric Analysis of Neoplastic Credentialing: for public health laboratory profes- Differential leukocyte count: pleural effusion sample
Hematolymphoid Cells; Approved Guideline— sionals, Feb 79 stability for white blood cell counts and, Nov
Second Edition (H43-A2), Nov 662 Crockcroft-Gault equations, May 301 685
Clinical Laboratory improvement Amendments of Cross-training, Nov 658 Digital glass slide technology: in digital pathology,
1988 (CLIA ’88): ISO 15189 and, May 279; Cryoglobulinemia, June 347 June 342; outsourcing of, July 391
proficiency testing required by, March 184, Cryptococcus neoformans: medically-important Digital imaging: ASCP cytology assessment pro-
April 237 yeasts, March 179, 180 grams for 2007, June 328; in digital patholo-
Clinical Laboratory Management Association (CLMA): “CSI” Exhibit (Museum of Science and Industry, gy, June 342
Good Practice Sharing program, Dec 713; in Chicago), Aug 456 Digital Imaging and Communications in Medicine
Legislative Symposium, March 137, 139, June CTx assay, May 276 (DICOM), June 339
332; ThinkLab 2007, March 149 Cuddy, Stephanie: on laboratory response to Virginia Digital pathology, June 341
Clinical laboratory science curriculum: teaching Tech shootirigs, July 396 1,25-Dihydroxy vitamin D: kidneys’ synthesis of,
research design and practice in, Oct 582 Cultures: guidelines and standards for blood cul- May 297
Clonality: flow cytometric assessment of T-ceil clon- tures, Oct 603; in yeast identification, March Direct antiglobulin test: possible transfusion reaction
ality in clinical specimens, Aug 477. See also 180 with positive, Dec 719
Monoclonal antibodies Current Procedural Terminology (CPT): ASCP nomi- Direct billing, Aug 459
Coagulation: autologous platelet concentrate for pro- nates experts to panels on, July 396; ASCP Disaster awareness: clinical laboratory students and,
duction of platelet gel, Jan 39; tube filling petitions for change in coding guidelines, July July 399
order's effect on specific parameters in 395 Disease-related malnutrition, Jan 43
healthy subjects, Sept 556. See also CXCR4 gene, Sept 551 Disseminated intravascular coagulation: in malig-
Anticoagulants Cyberloafing, Oct 591 nant hyperthermia, Feb 94
Coagulation factor inhibitors: hemophilia B in male Cystatin C: as renal function marker, May 301 DNA: automation and profiling of, July 409; molecu-
neonate, April 218 Cytogenetics: clinical significance in myeloprolifera- lar diagnostics technologies’ impact on refer-
Codabar: transition to ISBT 128 from, April 214 tive disorders, Feb 109; molecular cytogenet- ence laboratory testing in large urban aca-
Collagen: in osteoporosis, May 275, 276 ics in study of leukemia genome, Sept 527; demic medical center, Aug 475
College of American Pathologists (CAP): establish- “Test Your Knowledge,” July 443 Donation identification number, April 214
ment of, Oct 598; ISO 15189 and inspection Cytokine flow cytometry, July 432 Drug-induced ANCA vasculitis: Wegener's granulo-
checklists of, May 279; unannounced surveys, Cytology: at ASCP Annual Meeting, Sept 524; ASCP inatosis distinguished from, July 438
Jan 8 assessment programs for 2007, June 328; Drug resistance: “possible” HIV resistance, Jan 26
Colon: giant myelolipoma of the adrenal gland with proficiency testing regulations, May 265, June Duff, Ronald D: Papanicolaou Award for, Jan 12
adenocarcinoma of, Aug 491 331, Sept 519, 523; 2006 annual survey of Duncan, Carol S: on ASCP BOR accreditation, May
Communication: adverse outcomes due to lack of medical laboratory science programs, Aug 262
Jan 21; in conflict resolution, March 147; lab- 463; urine cytology and commercially avail- Dyshemoglobins: methemoglobinemia, Nov 663
oratory management at division level, Nov able urine-based markers for monitoring blad-
654; of laboratory test results, Nov 680 der urothelial carcinoma, Jan 48. See also E
Comparative genomic hybridization: automation of Gynecologic cytology eCourses, Feb 75, March 149, Aug 460
histology laboratory, July 409; in study of Cytomegalovirus (CMV): leukocyte reduction and “Editorial”: "Farewells and Greetings,” Nov 646
leukemia genome, Sept 529 plasma apheresis and levels of, Nov 676 Education: ASCP-ASCLS collaboration on, Sept 521;
Competitive bidding, Feb 73, April 204, June 327, Cytopenias: inbound versus outbound diagnoses for ASCP Student Scholarships program, May
Sept 523 leukemia/lymphoma samples submitted for 264; decline in number of laboratory training
Competitive protein binding radioimmunoassay: in flow cytometric analysis, April 241. See also programs, June 329; digital pathology in, June
aldosterone concentration measurement, Jan Thrombocytopenia 343; disaster awareness and clinical laborato-
29 ry students, July 399; laboratory management
Complement fixation test: for Histoplasma detection, “Day Without a Lab,” Sept 521 at division level, Nov 658; learning opportuni-
July 416 D-dimer: tube filling order's effect on specific coag- ties, March 149; National Student Honor
Condo” laboratories. See “Pod” laboratories ulation parameters in healthy subjects, Sept Awards, Feb 75, Aug 458; pathologist at “Ask
Confidence interval, Oct 583 556 the Expert Day” school program, June 333; for
Confronting problems, Nov 704 Decision making: laboratory management at division preventing proficiency testing failures, March
Congo red: in amyloidosis diagnosis, Sept 544 level, Nov 654 185; for public health laboratory scientists,
Continuing education: ASCP-ASCLS collaboration on, Decontamination: ultraviolet lamp monitoring in bio- Feb 79; teaching research design and practice
Sept 521: ASCP in development of, Oct 599 logical safety cabinets with cultures of stan- in MT/CLS curriculum, Oct 582; 2006 annual
for public health laboratory professionals, Feb dard bacterial strains, March 165 survey of medical laboratory science pro-
79. See also “Continuing Education Update” DeMay, Richard Mac: American Society of grams, Aug 463. See also Continuing educa-
series Cytopathology Excellence in Education Award tion
Continuing Education Update” series: autoimmune for, Jan 12 Electronic medical records (EMR): ASCP policy state-
hepatitis, April 248; avian influenza A (H5N1), Dengue fever, Jan 23 ment on, July 393; hospital information sys-
Dec 740; bladder cancer screening and future Deoxyhemoglobin, Nov 664 tem implementation for, May 317; laboratory
directions for urine-based markers for bladder Deoxypyridinolines: in bone resorption, May 276 reports in, June 339
urothelial carcinoma, Feb 116; differential Dexamethasone: in amyloidosis treatment, Sept 547 Electrophoresis: gel, for protein profiling, July 410;
diagnosis of Wegener's granulomatosis from Diabetes insipidus, May 298 in hemoglobin E disease diagnosis, Sept 541;
other small vessel vasculitides, July 437; feto- Diabetes mellitus: albuminuria as risk factor for car- two-dimensional, in prostate cancer research
maternal hemorrhage assessment is improved diovascular disease in patients with, Jan 35; and diagnostics, Dec 735
December 2007 « Volume 38 Number 12" LABMEDICINE 757
ADMeEAICING COM
Annual Index
Elution: possible transfusion reaction with positive July 434; B-globin gene cluster haplotype Global expression profiling: in study of leukemia
direct antigiobulin test, Dec 719 analysis as predictor of sickle ceil disease genome, Sept 530
E-mail: e-NewsBriefs, Sept 525 severity, Sept 563 a-Globin chains: in hemoglobin H disease, April 223
Emancipator, Kenneth: on ASCP BOR accreditation, Fetal lung maturity: testing in diabetic mothers, Sept fs-Globin gene cluster: haplotype analysis as predic-
May 262 553 tor of sickle cell disease severity, Sept 563
Embedding: automation and, July 407 Fetomaternal hemorrhage: flow cytometry for Glomerular basement membrane, Jan 36
Emergencies, chemical. See Chemical emergencies improving laboratory assessment of, June 365 Glomerular capillary wall, Jan 36
Employees: laboratory management at division level, Fibrin: degradation products as bladder cancer Glomerular filtration rate (GFR), May 299
Nov 655 tumor markers, Feb 117 Glomerulonephritis, May 298
End stage renal disease, May 299 Fibrinogen: degradation products as bladder cancer Glucose: requisition errors for blood glucose tests,
e-NewsBriefs, Sept 525 tumor markers, Feb 117; tube filling order's Sept 559
Enterobiasis, June 357 effect on specific coagulation parameters in Glucose-6-phosphate dehydrogenase (G6PD) defi-
Enterobius vermicularis, June 357 healthy subjects, Sept 556 ciency: and methemoglobinemia, Nov 663
Enterococcus fecalis: ultraviolet lamp monitoring in Fine-needle aspiration (FNA): in non-Hodgkin's lym- gamma-Glutamyltransferase (GGT), hepatoma-spe-
biological safety cabinets with cultures of phoma diagnosis, April 245 Cific: affinity chromatography for detection of,
standard bacterial strains, March 165 FIP1L1-PDGFRA: cytogenetics in myeloproliferative March 160
Enumeration of immunologically Defined Cell disorders, Feb 109 Glycosylation: of free prostate-specific antigen iso-
Populations by Flow Cytometry; Approved Fitzpatrick, Loretta: in African laboratory training forms, Dec 737
Guideline—Second Edition (H42-A2), Nov 661 programs, Feb 68 Golightly, Candace: in African laboratory training pro-
Enzyme immunoassay (EIA): laboratory testing to 5Ss, Feb 92, Nov 659 grams, Feb 68
identify individuals with inhalant allergies, Nov Fixation: automation and, July 406 Golightly, Marc: in African laboratory training pro-
649 Flaviviridae: dengue fever, Jan 23; hepatitis C virus, grams, Feb 68
Enzyme-linked immunosorbent assay (ELISA): multi- Feb 87 Gonzalez, Anthony H: Regional Member Award for,
plex antinuclear antibody assay compared Florida: bill exempting psycholugists from laboratory May 267
with, Nov 671 personnel laws, May 266, June 332 Good laboratory practices, March 184
Eosinophilia: hypereosinophilic syndrome, Feb 111; Flow cytometry, July 428; assessment of T-cell clon- Good Practice Sharing program, Dec 713
idiopathic eosinophilia associated CMML-2 ality in clinical specimens, Aug 477; fetoma- Grading: in teaching research design and practice,
with overexpression of ETV6 gene, Feb 100 ternal hemorrhage assessment is improved Oct 585
Epithelial growth factor: autologous platelet concen- using flow cytometry, June 365; inbound ver- Grams stain: in yeast identification, March 180, 181
trate for production of platelet gel, Jan 39 Sus outbound diagnoses for samples submit- Granulocyte-colony stimulating factor: in
Epstein-Barr virus (EBV): primary effusion lymphoma ted for analysis dy, April 240; in myelodysplas- myelokathexis treatment, Sept 551
associated with, March 150 tic syndrome diagnosis, May 305; in non- Graphic display of information, Oct 583
Eptifibatide: profound thrombocytopenia associated Hodgkin's lymphoma diagnosis, April 245; Gratama, Jan W: on H42-A2 guidelines, Nov 661
with administration of, Feb 97 “Test Your Knowledge,” Nov 695; updated Grave's disease: thyrotoxicosis hypokalemic periodic
Equipment: personal protective equipment in chemi- methodologies for enumeration of cell popula- paralysis and, Oct 615
cal terrorism preparedness, Feb 81. See also tions by flow cytometry, Nov 661 Great Wall effect, Aug 483
Instrumentation Fluorescein, July 430 Grossing: automation and, July 406
Erythropoietin: kidneys’ synthesis of, May 297 Fluorescence in situ hybridization (FISH): automation Growth factors: autologous platelet concentrate for
Escherichia coli: ultraviolet lamp monitoring in bio- of, July 408; for myeloproliferative disorders, production of platelet gel, Jan 39
logical safety cabinets with cultures of stan- Feb 109; in study of leukemia genome, Sept Guidelines: for preventing proficiency testing fail-
dard bacterial strains, March 165 528 ures, March 185. See also “Lab Guidelines &
Estrogen: osteoporosis and deficiency of, May 275, Fluorescence resonance energy transfer, July 430 Standards”
277 Fluorochromes, July 430 Guyana, July 392
Ethics: online study of unethical events, Dec 750(let- Food and Drug Administration (FDA): on blood com- Gynecologic cytology: ASCP GYN PT, Feb 69, April
ter) ponent labeling, April 214; genetic test for 200, June 336; versus new era in cervical
Ethylene diamine tetraacetic acid (EDTA): K2, mixing recurrence of breast cancer approved by, May cancer screening and prevention, May 260.
procedures’ effects on hematological samples, 265; “home brew” test regulation proposed See also Liquid-based cytology; Papanicolaou
Dec 723 for, June 332 tests (Pap smears)
ETV6 gene: idiopathic eosinophilia associated Forensics: “CSI” Exhibit, Aug 456 GYN PT, Feb 69
CMML-2 with overexpression of, Feb 100 Forensic toxicology: career alternative for phie-
botomists in, May 271 H
F
Freeman, Vicki: in African laboratory training pro- Haplotype analysis: of {3-globin gene cluster, as pre-
Factor V Leiden: tube filling order's effect on specific grams, Feb 68 dictor of sickle cell disease severity, Sept 563
Coagulation parameters in healthy subjects, Fungi. See Mycology Harrier, Claudia: on ASCP qualification in laboratory
Sept 556 Fusobacterium necrophorum, July 414 informatics, March 134
Factor IX: in hemophilia B, April 218 Hazardous materials: chemical terrorism prepared-
Fas: as bladder cancer tumor marker, Feb 118 G ness, Feb 81
F-cell enumeration: for fetomaternal hemorrhage Gako, Neil Anthony N: on international certification, Hazard ratio, Oct 583
detection, June 367 June 326 Health care reform, April 203
“Features”: ASCP: the pathology society of “firsts,” Garduque, Carlo Emmanuel V: on international certi- Health Level 7 (HL7), June 339
Oct 595; automation of histology laboratory, fication, June 337 Health Resources and Services Administration
July 405; basics of osteoporosis and use of Gel electrophoresis: for protein profiling, July 410 (HRSA): Public Health Work Force Enumeration
bone markers, May 273; conflict resolution, Gender discrepancy: ASCP Board of Registry survey, Feb 77
March 145; digital pathology, June 341; flow research 1993-2007, an annotated bibliogra- Heart: cardiac amyloidosis secondary to multiple
cytometric assessment of T-cell clonality in phy, Oct 589, 591 myeloma, £2pt 543; pericardial effusion,
Clinical specimens, Aug 477; hepatitis C virus, Genetic Information Nondiscrimination Act (HR 493), March 150. See also Cardiac markers;
Feb 85; ISBT 128, April 213; laboratory man- Aug 459 Cardiovascular disease
agement at division level, Nov 651; molecular Genetics. See Cytogenetics; Genotyping Heart sounds, muffled: in primary effusion lym-
cytogenetics in study of leukemia genome, Genomics and Personalized Medicine Act (S 976), phoma, March 150
Sept 527; root cause analysis in laboratory June 332 Hemacytometry: for sperm counting, April 232
medicine, Dec 709; specific IgE testing, Jan Genotypic resistance assays: “possible” HIV resist- Hemagglutinin: in influenza viruses, Dec 740
17 ance, Jan 26 Hematology: centrifugation time’s effect on stat clin-
Fee splitting, March 135 Genotyping: and hepatitis C virus predictor of treat- ical chemistry testing, March 172; flow cytom-
Fell, Linda L: in African laboratory training programs, ment outcome, Feb 88 etry in, July 432; and ISBT 128, April 214;
Feb 68; ASCP Member Excellence in Education Germ tube: in yeast identification, March 181 mixing procedures for K2 EDTA primary sam-
Award for, March 136, 137 Gill, Gary: leaves LABMEDICINE Editorial Advisory ples’ effects on hematological samples, Dec
Fetal hemoglobin: flow cytometry for detection of, Board, Nov 646 723; proficiency testing performance in
758 LABMEDICINE ® Volume 38 Number 12 December 2007
labmedicine.com
Annual Index
physician's office, clinic, and small hospital cervical cancer, May 260, 269; genetic test for drome, July 413; Moraxella catarrhalis patho-
laboratories, 1994-2004, April 237 and Pap testing, April 198 genicity, July 420; state public health labora-
Hematoxylin and eosin (H&F* staining: automation Human resources depattments, Nov 652 tories surveyed for pertussis diagnostics,
and, July 407 Hurricane Katrina: cholera as result of, Nov 689 March 169; Vibrio in the United States, Nov
Hematuria screening, Feb 116 Hyaluronic acid: as bladder cancer tumor marker, 688; Zygomycetes in patient with systemic
Hemodialysis. See Dialysis Feb 117 lupus erythematosus, Aug 487. See also
Hemoglobin: methemoglobinemia. Nov 663. See also Hyaluronidase: as bladder cancer tumor marker, Feb Acquired immunodeficiency syndrome (AIDS)
Fetal hemoglobin; Hemoglobinopathies 117 Influenza: avian influenza A (H5N1), Dec 740
Hemoglobin E disease, Sept 539 Hypereosinophilic syndrome: cytogenetics in myelo- Informatics: ASCP qualification in, March 134
Hemoglobin H disease, April 222 proliferative disorders, Feb 111 Information technology: ASCP adopts health infor-
Hemoglobinopathies: {3-globin gene cluster haplo- Hyper-immunoglobulin M syndrome: flow cytometry mation technology policy, July 396; ASCP
type analysis as predictor of sickle cell dis- in diagnosis of, July 431 qualification in laboratory informatics, March
ease severity, Sept 563; hemoglobin E dis- Hypersensitivity. See Allergies 134; digital pathology, June 341; hospital
ease, Sept 539; hemoglobin H disease, April Hypertension: albuminuria as risk factor for cardio- information system implementation, May 317
222 vascular disease in patients with, Jan 35 inhalant allergies: laboratory testing to identify indi-
Hemolytic uremic syndrome, Oct 610 Hyperthermia: malignant, Feb 94 viduals with, Nov 649
Hemophilia: in male neonate, April 218 Hyperthyroidism: thyrotoxicosis hypokalemic period- In situ hybridization: automation of, July 408. See
Henry, Judy: on ASCP Certification Maintenance ic paralysis and, Oct 615 also Fluorescence in situ hybridization (FISH)
Program, Jan 13 Hyperuricemia: and arthralgias during pyrazinamide Instrumentation: Laboratory instrument
Heparin: laboratory monitoring of, Aug 499 therapy in patients with pulmonary tuberculo- Implementation, Verification, and Maintenance;
Hepatitis: autoimmune, April 248. See also Hepatitis sis, Aug 495 Proposed Guideline (GP31-P), Dec 715; pur-
C virus Hyperzincuria, Oct 608 chased versus rented, April 207. See also
Hepatitis C virus (HCV), Feb 85; new blood banking Hyphae, March 181 Automation
guidelines to prevent transmission of, July Hypokalemia: thyrotoxicosis hypokalemic periodic Interface hepatitis, April 249
395 paralysis, Oct 614 Interferons: in hepatitis C virus infection treatment,
Hepatoma-specific GGT: affinity chromatography for Feb 89
detection of, March 160 | Interleukin-12 (IL-12): 3'UTR polymorphism of IL12B
High-performance liquid chromatography (HPLC): for ICCBBA (International Council for Commonality in in relation to susceptibility and development of
microalbuminuria testing, Jan 37 Blood Bank Automation), April 214 diabetes, May 289
Hilborne, Lee H: installed as ASCP president, Sept 1L12B gene: 3'UTR polymorphism of in relation to International Prognostic Index: for non-Hodgkin's
518; on President's Emergency Program for susceptibility and development of diabetes, lymphoma, April 244
AIDS Relief, Aug 458 May 289 Internet. See World Wide Web (WWW)
Histochemistry: automation of, July 408 Image-analysis algorithms, June 343 Interphase fluorescence in situ hybridization (FISH):
Histology: automation in, July 405; teaser, Oct 581; Imaging: for bone health assessment, May 275; in in study of leukemia genome, Sept 528
2006 annual survey of medical laboratory sci- non-Hodgkin's lymphoma diagnosis, April 245. Intrachromosomal amplification of chromosome 21,
ence programs, Aug 463 See also Digital imaging Sept 530
Histomorphometry: for bone health assessment, May immunoassays: hepatitis C virus testing, Feb 87; for Intrauterine growth retardation: iron status at birth
275 microalbuminuria testing, Jan 37; serum thy- and, Feb 105
Histoplasma capsulatum, June 352, July 416 roglobulin stability for, Oct 618 Iron deficiency: diagnosis in infants, Feb 103; micro-
Histoplasmosis, disseminated, June 352, July 416 Immunocomplex substitution reaction: in radioim- cytic anemia caused by, April 222; in
HIV. See Human immunodeficiency viruses (HIV) munoassay of aldosterone, Jan 29 Moraxella catarrhalis, July 420
HLA alloantibody: flow cytometry for detection of, ImmunoCyt: for monitoring bladder urothelial carci- ISBT 128, April 213
July 433 noma, Jan 49 ISO 15189, May 279, June 330
Holladay, E Blair: on ASCP BOR accreditation, May Immunodeficiency disorders: flow cytometry in diag-
262; on California approving MT(ASCP) certifi- nosis of, July 431. See also Human immunod- J
cation for licensure, Jan 15; on Certification eficiency viruses (HIV) Jacobs, Jeff: and “pod” laboratories campaign, Aug
Maintenance Program, Aug 454, 460 Immunodiffusion: for Histoplasma detection, July 459
Holladay, Suzanne: on laboratory response to 416 Jaffé reaction: nitromethane interferes with, Dec 717
Virginia Tech shootings, July 390, 396 Immunofluorescence assay: multiplex antinuclear JAK (Janus Kinase)-2 gene, Feb 114
Homburger, Henry: on allergy testing, Nov 650 antibody assay compared with, Nov 671 Jamieson, Bette: in African laboratory training pro-
“Home brew” tests: genetic test for recurrence of Immunoglobulin E (IgE): specific IgE testing, Jan 17, grams, Feb 68
breast cancer, May 265; regulation proposed Nov 649; total and specific IgE in sera of Job responsibilities scale, Oct 588
for, June 332 patients with asthma, urticaria, of allergic Jobs. See Career development
Homeostasis: renal, May 297 rhinitis, Oct 621 Joint Commission on Accreditation of Healthcare
Hornick, Joanna C: Regional Member Award for, May Immunoglobulin G (IgG): in hospital and clinical labo- Organizations (JCAHO): on adverse outcomes
267 ratory response to mumps exposure, May due to lack of communication, Jan 21; ISO
Hospital information systems: implementation of 285; neuromyelitis optica antibodies, Oct 605 15189 and standards of, May 279; patient
May 317 Immunoglobulins: in amyloidosis, Sept 545, 546; in safety initiative, Jan 7; tracer methodology of,
Hospital laboratories: preficiency testing perform- cryoglobulinemia, June 347 Jan 8; unannounced surveys, Jan 8
ance in physician's office and clinic laborato- Immunohistochemistry: automation of, July 408
ries and, 1994-2004, April 237 Immunophenotyping: flow cytometric assessment of K
Hospitals: chemical terrorism preparedness in, Feb T-cell clonality in clinical specimens, Aug 477; Kan-ban system, Nov 659
81; implementation of hospital information flow cytometry in, July 433; inbound versus Kansas: direct billing legislation in, June 332
systems, May 317 outbound diagnoses for samples submitted for Kearns, Ellen Hope: on laboratories in Guyana, July
Howell-Jolly bodies: in babesiosis patient, May 282 flow cytometric analysis, April 240; in non- 392
HPV. See Human papillomavirus (HPV) Hodgkin's lymphoma diagnosis, April 245 Kidneys: albuminuria in disease detection, Jan 35;
Human chorionic gonadotropin (hCG): false-positives India ink: in yeast identification, March 180 renal function tests, May 295; transplantation,
in urine pregnancy testing in women with can- Infants: iron deficiency diagnosis in, Feb 103. See May 303 :
cer, May 280 also Neonates Kirkley, Barbara: on CLSI's The Key to Quality, June
Human herpesvirus-8: primary effusion lymphoma Infectious diseases: avian influenza A (H5N1), Dec 376
associated with, March 150 740; dengue fever, Jan 23; disseminated Kleihauer-Betke method, June 365
Human immunodeficiency viruses (HIV): African lab- histoplasmosis, June 352, July 416; hepatitis Kozlowski, Susan: at ASCP Leadership Exchange,
oratory training programs, Feb 68, June 335; C virus infection, Feb 85; hospital and clinical Jan 6
coinfection with hepatitis C virus, Feb 90; laboratory response to mumps exposure, May Kroft, Steven: leaves LABMEDICINE Associate Editor
“possible” HIV resistance, Jan 26. See also 285; hyperuricemia and arthralgias during post, Nov 646
Acquired immunodeficiency syndrome (AIDS) pyrazinamide therapy in patients with pul- K2 EDTA: mixing procedures’ effects on hematologi-
Human papillomavirus (HPV): as etiologic agent of monary tuberculosis, Aug 495; Lemierre’s syn- cal samples, Dec 723
December 2007 ® Volume 38 Number 12@LABMEDICINE 759
labmedicine.com
Annual Index
Kuernmel, Susan: Regional Member Award for, May from liquid-based (SurePath) preparations and Medically Unbelievable Edits (MUE) proposal, March
267 conventional Pap smears for cervicovaginal 135, June 331
screening, Dec 729 Medical Technology Today, Sept 525
L Listening, Nov 654 Medicare: Physician Fee Schedule, March 139, Sept
“Lab Guidelines & Standards”: blood cultures, Oct Lithium self-intoxication treated with hemodialysis, 523
603; instrumentation, Dec 715; managing - Nov 667 Medscape, June 334
nonconforming laboratory events, Sept 537; Liver: autoimmune hepatitis, April 248; hepatitis C Melphalan: in amyloidosis treatment, Sept 547
updated methodologies for enumeration of cell virus infection, Feb 85; hepatoma-specific Menopause: bone marker concentration and, May
populations by flow cytometry, Nov 661 GGT detection by affinity chromatography, 277
LABMEDICINE: Editorial Advisory Board changes, March 160; malignant hyperthermia in necro- Methemoglobinemia, Nov 663
Nov 646; readership survey, Jan 56; share sis of, Feb 94 Metzler, Rhonda: and ASCP and cytology proficiency
your reality lab stories with, June 334 Local representatives, Jan 9 testing, April 200
Laboratory instrument Implementation, Verification, Locus-specific fluorescence in situ hybridization Microalbuminuria: in disease detection, Jan 35
and Maintenance; Proposed Guideline (GP31- (FISH), Sept 528, 533 Microangiopathic hemolysis: in thrombotic thrombo-
P), Dec 715 Long-QT syndrome, July 401 cytopenic purpura/hemolytic uremic syn-
Laboratory Response Network (LRN), Feb 78 Low-molecular-weight heparin: laboratory monitor- drome, Oct 610
Laboratory Test Improvement Act (S 736), June 332 ing of, Aug 499 Microbiology: and ISBT 128, April 214; proficiency
LabQ: for certification maintenance, April 204, Aug Lungs: hyperuricemia and arthralgias during pyrazi- testing performance in physician's office, clin-
460; 2007 Manuscript of the Year, July 440 namide therapy in patients with pulmonary ic, and small hospital laboratories,
Labs Are Vital Web site, May 266 tuberculosis, Aug 495; Lemierre’s syndrome, 1994-2004, April 237. See also Bacteria;
Lactophenol cotton blue: in yeast identification, July 413; Zygomycetes in patient with sys- Virology
March 180 temic lupus erythematosus, Aug 487 Microcytosis: in hemoglobin E disease, Sept 539
Land, Kevin: becomes LABMEDICINE Associate Lupus erythematosus, systemic: Wegener’s granulo- Microdissection platforms: automated, July 408
Editor, Nov 646 matosis distinguished from, July 438; Micronutrients, Jan 43
Laser-capture microdissection: in automation of his- Zygomycetes in patient with, Aug 487 Microsatellites: as bladder cancer tumor markers,
tology laboratory, July 409, 410 Lurie, Joanna E: ASCP Member Lifetime Feb 118
Latchaw, Perthena: in African laboratory training Achievement Award for, March 136, 137 Microscopy: in digital pathology, June 341; in yeast
programs, Feb 68 Lymph node biopsy: in non-Hodgkin's lymphoma identification, March 179
Leadership: ASCP Leadership Exchange, Jan 6, Feb diagnosis, April 245 Microtomy: automation and, July 407
72, March 137, 149, May 267, 268; avoiding Lymphocyte subsets: flow cytometry in enumeration Minnesota Clinical Laboratory Collaborative, March
tantrum-like behavior, Dec 768; at division of, July 431 138
level, Nov 652; succession planning, May 263 Lymphoma: flow cytometry in immunophenotyping Missouri: billing legislation in, Aug 459
Lean, Jan 6, March 143, Nov 659 of, July 433; inbound versus outbound diag- Modification of Diet in Renal Disease study equation,
Lee-White whole biood clotting time, Aug 500 noses for samples submitted for flow cytomet- May 300
Legislation: ASCP-ASCLS collaboration on, Sept 521 ric analysis, April 240; non-Hodgkin's lym- Mohapatra, Surya: on primary-care allergy testing,
Legislative Symposium 2007, March 137, 139, phoma diagnosis, April 244; primary effusion, Nov 649
Sept 521 March 150 Molecular diagnostics: impact on reference labora-
Legislative Symposium, March 137, 139, Sept 521 Lymphoproliferative disorders: inbound versus out- tory testing in large urban academic medical
Lemierre’s syndrome, July 413 bound diagnoses for leukemia/lymphoma center, Aug 472; molecular cytogenetics in
Length of stay: malnutrition associated with samples submitted for flow cytometric analy- study of leukemia genome, Sept 527; in new
increased, Jan 45 sis, April 243; T-cell receptor-VB analysis for era in cervical cancer screening and preven-
Lersch, Ann H: on Pap testing, April 198 diagnosis of T-cell, Aug 479 tion, May 260; for non-Hodgkin's lymphoma,
Leukemia: clinical significance of cytogenetics in April 245
myeloproliferative disorders, Feb 109; flow M Molina, Thomas: becomes LABMEDICINE IT Editor,
cytometry in immunophenotyping of, July 433; Macronutrients, Jan 43 Nov 646
idiopathic eosinophilia associated CMML-2 Makiler chambers: for sperm counting, April 232 Monoclonal antibodies: anti-HbF antibodies for feto-
with overexpression of ETV6 gene, Feb 100; Malaria: case study of, March 153 maternal hemorrhage detection, June 366; in
inbound versus outbound diagnoses tor sam- Malassezia furfur: medically-important yeasts, flow cytometry, July 430; in specific IgE test-
ples submitted for flow cytometric analysis, March 179 ing, Jan 18
April 240; molecular cytogenetics in study of Malignant hyperthermia, Feb 94 Montana: bill on offering tests directly to patients,
genome of, Sept 527; multiparametric flow Malnutrition, Jan 43 June 332
cytometry in diagnosis of myelodysplastic Mammography Quality Standards Act, June 331 Montgomery Regional Hospital (Blacksburg, VA), July
syndromes and related disorders, May 305 Management: conflict resolution, March 145; at divi- 390
Leukocyte adhesion deficiency: flow cytometric sion level, Nov 651; nonconforming laboratory Moraxella catarrhalis: causes of pathogenicity of,
determination of, July 432 event management, Sept 537; purchasing ver- July 420
Leukocyte reduction: and cytomegalovirus DNA lev- sus renting laboratory instruments, April 207 Morphology agars: in yeast identification, March 181
els in samples, Nov 676; flow cytometry for See also Accreditation; Quality assurance; M-spike, biclonal, June 347
measuring residual white cells in ieukocyte- Staffing Multicolor fluorescence in situ hybridization (FISH):
reduced blood, July 434 Management of Nonconforming Laboratory Events in study of leukemia genome, Sept 528
Leukocytosis: inbound versus outbound diagnoses (HS12-P), April 217 Multiple inhalant allergen test (MIA), Nov 650
for leukemia/lymphoma samples submitted for Management of Nonconforming Laboratory Events; Multiple myeloma: cardiac amyloidosis secondary
flow cytometric analysis, April 242 Proposed Guideline (GP32-P), Sept 537 to, Sept 543
Leukopenia: in dengue fever, Jan 23 Mass spectroscopy: for prostate cancer diagnosis, Multiple sclerosis: neuromyelitis optica distinguished
Levin, Bernard: on ASCP and cytology proficiency Dec 737; for protein profiling, July 410 from, Oct 606
testing, April 200 Maternal fetal iron transport, Feb 104 Multiplex antinuclear antibody assay: in pediatric
Lewis X antigen: as bladder cancer tumor marker, Matrix-assisted laser desorption ionization time of patients, Nov 671
Feb 118 flight: for protein profiling, July 410 Mumps: hospital and clinical laboratory response to
Licensure: ASCP-ASCLS collaboration on, Sept 521 Matrix Meeting, Feb 70, Sept 522 exposure to, May 285
ASCP “Fix the Law” campaign in New York State, McGeary, Jennifer K: on Laboratory Instrument ‘Mycology: flow cytometric antifungal susceptibility
May 265, July 395, Aug 460; California approves Implementation, Verification, and Maintenance; testing, July 434; Histoplasma capsulatum,
MT(ASCP) certification for, Jan 15; for phie- Proposed Guideline (GP31-P), Dec 715 June 352, July 416; medically-important
botomists, June 377 (letter); workforce chal- McKenna, Barbara: at ASCP Matrix Meeting, Feb 70; yeasts, March 178; “Test Your Knowledge,”
lenges in public health laboratory system, Feb 79 meets with Representative Walberg, Sept 523 Dec 749; Torulopsis (Candida) glabrata and
Linear regression, Oct 583 Medenilla, Agnes B: on international certification, Candida krusei identification using calcofluor
Liquid-based cytology: versus new era in cervical June 326, 337 white, April 227; Zygomycetes in patient with
cancer screening and prevention, May 260, “Media Review”: LabOQ 2007 Manuscript of the Year, systemic lupus erythematosus, Aug 487
269; rejected and unsatisfactory specimens July 440 Myelodysplastic syndromes: inbound versus out-
768 LABMEDICINE ® Volume 38 Number 12 © December 2007
labmedicine.com
Annual Index
bound diagnoses for leukemia/lymphoma Organization: 5Ss for achieving, Feb 92 Phosphatidylcholine, disaturated: in fetal lung matu-
samples submitted for flow cytometric analy- Organ transplantation. See Transplantation rity testing, Sept 553
sis, April 243; multiparametric flow cytometry Orthomyxoviridae, Dec 740 R-Phycoerythrin, July 430
in diagnosis of, May 305 Osteocalcin: as biological marker of bone metabo- Physician office laboratories (POLs): proficiency test-
Myelofibrosis: chronic idiopathic, Feb 113 lism, May 276 ing performance in clinic and small hospital
Myeloid antigen expression: in multiparametric flow Osteoporosis: basics of and use of bone markers, laboratories and, 1994-2004, April 237
cytometric diagnosis of myelodysplastic syn- May 273 Physicians: Medicare Physician Fee Schedule, March
dromes and related disorders, May 307 Outsourcing: of digital slide imaging, July 391 139, Sept 523
Myelokathexis, Sept 549 Overtime, Nov 658 Picture archiving and communication systems, June
Myelolipoma: giant, of the adrenal gland with adeno- Oximetry, CO-: in methemoglobinemia diagnosis, 339, 343
carcinoma of the colon, Aug 491 Nov 663 Pinworm, June 357
Myeloproliferative disorders: clinical significance of Placenta: examination of, Oct 624
cytogenetics in, Feb 109; inbound versus out- P Planning: for chemical terrorism preparedness, Feb
bound diagnoses for leukemia/lymphoma Pancreatic cancer: CA 19-9 elevation in, Aug 486 82
samples submitted for flow cytometric analy- Pancytopenia: in case studies, June 347 Plasma: chemiluminescent assay for choline analy-
sis, April 242 Papanicolaou tests (Pap smears): human papillo- sis in whole blood and, Dec 726; leukocyte
Myers, Jeffrey L: at ASCP Matrix Meeting, Feb 70 mavirus testing and vaccine and, April 198; reduction, plasma apheresis, and
versus new era in cervical cancer screening cytomegalovirus DNA !evels in samples, Nov
N and prevention, May 260, 269; rejected and 676; platelet-rich, autologous platelet concen-
National Accrediting Agency for Clinical Laboratory unsatisfactory specimens from liquid-based trate for production of platelet ge!, Jan 39
Sciences (NAACLS), Oct 599 (SurePath) preparations and conventional, Dec Plasminogen: tube filling order's effect on specific
National Labor Relations Board (NLRB), Jan 11 729 coagulation parameters in healthy subjects,
National Medical Laboratory Professionals Week, Papillomavirus. See Human papillomavirus (HPV) Sept 556
Jan 14, March 137, April 199, May 264, July Pappenheimer bodies: in babesiosis patient, May Plasmodium falciparum: malaria due to infection
394, Sept 521, Oct 599 282 with, March 153
National Student Honor Awerds, Feb 75 Paralysis: thyrotoxicosis hypokalemic periodic, Oct Platelet-derived growth factor: autologous platelet
Nauman, Nick: on Lean, March 143 614 concentrate for production of platelet gel, Jan
Nayar, Ritu: on volunteering, Aug 454 Parasitology: enterobiasis, June 357 39
Nebraska: billing legislation in, June 332 Paroxysmal nocturnal hemoglobinuria: flow cytome- Platelet glycoprotein inhibitors: thrombocytopenia
Necrosis: ,adiation, March 157 try in testing for, July 432 associated with, Feb 97 ,
Neisseria sicca/subf!2va: continuous ambulatory Parsons, Barbara: on CLSI’s The Key to Quality, June Platelet-rich plasma:.autologous platelet concentrate
peritoneal dialysis-associated peritonitis 376 for production of platelet gel, Jan 39
involving, June 363 Partial thromboplastin time (PTT): with hemophilia B, Platelets: autologous platelet concentrate for pro-
Neonates: fetal lung maturity testing in diabetic moth- April 218 duction of platelet gel, Jan 39; profound
ers, Sept 553; placental examination, Oct 624 Pathologists’ assistants: 2006 annual survey of thrombocytopenia associated with administra-
Nephritis, autoimmune, May 298 medicai laboratory science programs, Aug 463 tion of eptifibatide, Feb $7
Nephrotic syndrome, May 298 Patient information: digitizing, May 317; improved Pleural effusions: sample stability for white blood
Neuraminidase: in influenza viruses, Dec 740 communication for, Jan 21 Cell and differential counts, Nov 685
Neuromyelitis optica, Oct 605 Patient outcomes: nutritional status and, Jan 45 “Pod” laboratories: ASCP campaign to stop, March
Neuropathy: with hyperzincuria, Oct 608 Patients: communicating laboratory test results to, 135, April 203, June 331, Aug 459, Sept 519,
Neutropenia: myelokathexis, Sept 549 Nov 680. See also Patient information; Patient 523; billing abuses by, Jan 11, Feb 73, March
Neutrophil function: flow cytometry in evaluation of, safety 135
July 431 Patient safety: at ASCP Leadership Exchange, Feb Point-cf-care (POC) tests: ASCP Board of Registry
New York State: ASCP Board of Registry exams rec- 72; improved communication for, Jan 21; lab- research 1993-2007, an annotated bibliogra-
ognized in, Jan 11; ASCP “Fix the Law” cam- oratory professionals as uniquely qualified to phy, Oct 588; phiebotomy affected by, March
paign in, May 265, July 395, Aug 460 contribute to, Jan 7 140
Nickel, Christina: undocumented cis-AB locus Patton, Eileen M: Regional Member Award for, May Polyangiitis, microscopic: Wegener's granulomatosis
detected by, June 334 268 distinguished from, July 438
Nickel, Karen L: on California approving MT(ASCP) Peck, Margaret: on JCAHO unannounced surveys, Polychromatic flow cytometry, July 434
certification for licensure, Jan 15 Jan 8 Polycythemia: inbound versus outbound diagnoses
Nicotinamide adenine dinucleotide phosphate Pegylation: in hepatitis C virus infection treatment, for leukemia/lymphoma samples submitted for
(NADPH): in methemoglobinemia treatment Feb 90 flow cytometric analysis, April 242. See also
Nov 664 Performance improvemerit: AMA Physician Polycythemia vera
Nitromethane: false-positive creatinine value due to Consortium for Performance Improvement, Jan Polycythemia vera: and cytogenetics in myeloprolif-
ingestion of, Dec 717 12; root cause analysis for, Dec 710 erative disorders, Feb 112
Noble, Michael: on CLSI’s The Key to Quality, June Pericardial effusion: in primary effusion lymphoma Polymerase chain reaction (PCR): for avian influenza
376 March 150 A (H5N1) virus detection, Dec 743; for pertus-
Nonconforming laboratory events: management of Peritonitis: continuous ambulatory peritoneal dialy- sis diagnosis, March 169
April 217, Sept 537 sis-associated, involving Neisseria sicca/sub- Portable Document Format (PDF), June 339
Non-Hodgkin's lymphoma: diagnosis of, April 244 flava, June 363 Postperfusion syndrome: cytomegalovirus in, Nov
NTx assay, May 276 Perrigoue, Signe: on ASCP qualification in laboratory 676
Nuclear matrix protein (NMP) 22 tests: for monitor- informatics, March 134 Potassium: in thyrotoxicesis hypokalemic periodic
ing bladder urcihelial carcinoma, Jan 49 Personal protective equipment: in chemical terrorism paralysis, Oct 614
Nucleic acid testing: in hepatitis C virus testing, Feb preparedness, Feb 81 Potassium hydroxide: in yeast identification, March
88 Pertussis: state public health laboratories surveyed 180
NUP214-ABL amplification, Sept 531 for diagnostics for, March 169 Prealbumin: as nutritional status marker, Jan 45
Nursing: NLRB ruling on nursing supervisors, Jan 11 Petechiae, Jan 23 Pregnancy: fetal lung maturity testing in diabetic
Nutrition: assessment of, Jan 43 Pharmaceutical research: digital pathology in, June mothers, Sept 553: urine testing in women
344 with cancer, May 280
0 Phenotypic resistance assays: “possible” HIV resist- President's Emergency Program for AIDS Relief
Obesity: waist circumference and biomarkers for ance, Jan 26 (PEPFAR), Feb 68, Aug 457, 458
diabetes and cardiovascular disease in healthy Philadelphia (Ph) chromosome, Sept 528 “President's Message”: “Digital Slide Imaging: Is
non-obese women, July 422 Phlebotomy: career alternative in forensic toxicology, Outsourcing Coming Next?”, July 391; “Entire
Odds ratio, Oct 583 May 271; as link in laboratory chain, March Laboratory Team Urged to Join Campaign to
O'Leary, Michael R: on JCAHO unannounced sur- 140, June 377(letter), Sept 571 (letter); 2006 Ends Pod Labs,” March 135; “Lab Week '07—
veys, Jan 8 annual survey of medical laboratory science It's All About Quality and Service,” April 199;
Optic neuritis: in neuromyelitis optica, Oct 605 programs, Aug 463 “Maintenance of Certification: What Everyone
December 20#0V o7lum e 38 Number 12@LABMEDICINE 761
aMedicine
Annual Index
Should Know,” Aug 455; “Old, Older, Oldest: conforming laboratory event management, Resident-in-Service Examination (RISE), Feb 69
Another ASCP Milestone,” May 261; “Ongoing Sept 537; for preventing proficiency testing Residents: in ASCP, Feb 69
Improvements at ASCP.” Feb 69; “Resolved: To failures, March 185, 186; Quality Qorner, Jan Respiratory distress syndrome: fetal lung maturity
Make Ourselves and Our Patients Better,” Jan 7; 21, Feb 92, March 149, April 217, May 279, testing in diabetic mothers to predict risk of,
“Ship to Shore: Thank You for the Voyage!” ,S ept June 345, July 411, Avg 483, Sept 536, Oct Sept 553
519; “You Can Be the Message!”, June 327 *602, Nov 659, Dec 713; root cause analysis Retinol binding protein: as nutritional status marker,
Preterm delivery: postnatal iron deficiency and, Feb in, Dec 709; Six Sigma, Jan 6, March 143 Jan 45
105 Quality-management systems: for meeting ISO Retirement: succession planning for, May 263
Price, Catherine D: on ASCP qualification in laborato- 15189 requirements, May 279 Review: albuminuria in disease detection, Jan 35;
ry informatics, March 134, 141 Quality System Essentials, May 279 autologous platelet concentrate for production
Problem solving: confronting problems for, Nov 704; Quanticyt: in bladder cancer screening, Feb 118 of platelet gel, Jan 39; cytogenetics in myelo-
4-step process for, March 192 proliferative disorders, Feb 109; flow cytome-
Procollagen amino-terminal propeptide, May 276 R try theory and applications, July 428; (s-globin
Procollagen carboxy-terminal propeptide, May 276 Rabinovitch, Albert: on Laboratory Instrument gene cluster haplotype analysis as predictor of
Professionalism. See Certification; Licensure; Implementation, Verification, and Maintenance; sickle cell disease severity, Sept 563; iron
Proficiency testing Proposed Guideline (GP31-P) in, Dec 715 deficiency diagnosis in infants, Feb 103; med-
Proficiency testing, March 184; ASCP GYN PT, Feb Radar graphs, June 377(letter) ically-important yeasts, March 178; non-
69, April 200, June 336; cytology regulations, Radiation therapy: radiation necrosis as side effect Hodgkin's lymphoma diagnosis, April 244;
May 265, June 331, Sept 519, 523; perform- of, March 157 nutritional assessment, Jan 43; renal function
ance in physician's office, clinic, and small Radioa'lergosorbent test (RAST): laboratory testing to tests, May 295; two-dimensional elec-
hospital laboratories, 1994-2004, April 237 identify individuals with inhalant allergies, Nov trophoresis in prostate cancer research and
Progenitor cells: flow cytometry for enumeration of 649; specific IgE testing, Jan 18 diagnostics, Dec 735
CD34+ stem cells and, July 433 Radioimmunoassay (RIA): of aldosterone, immuno- Rhabdomyolysis: in malignant hyperthermia, Feb 94
Prostate cancer: two-dimensional electrophoresis in complex substitution reaction in, Jan 29; labo- Rh immune globulin: in fetomaternal hemorrhage
diagnosis of, Dec 735 ratory testing to identify individuals with treatment, June 365
Prostate-specific antigen: two-dimensional elec- inhalant allergies, Nov 649 Rhinitis, allergic, Jan 18; total and specific IgE in
trophoresis in prostate cancer diagnosis, Dec Ramsammy, Leslie S: on laboratories in Guyana, July sera of patients with, Oct 621
735 392 Ribonucleic acid expression profiling: automation
Protein C: tube filling order's effect on specific coag- Rapid trehalose: in yeast identification, March 181 and, July 409
ulation parameters in healthy subjects, Sept Reagent rental and leasing, April 207 Riegert, Cecilia: on laboratory response to Virginia
556 “Reality Lab Stories”: laboratory suggests things the Tech shootings, July 390, 396
Protein S: tube fiiling order's effect on specific coag- physician had not yet considered, Sept 520 Risk management, March 192
ulation parameters in healthy subjects, Sept Records. See Electronic medical records (EMR) Robinson, Cathy: in African laboratory training pro-
556 Reference laboratories: molecular diagnostics tech- grams, Feb 68
Proteins: automated profiling, July 409; in nutritional nologies’ impact on, Aug 472 Rodriguez, Fred H, Jr: on ASCP and cytology profi-
assessment, Jan 43. See also Proteomics “Relationships under the Microscope”: accountabili- ciency testing, April 200
Proteomics: two-dimensional electrophoresis in ty, Sept 576; clear agreements, June 384; Root cause analysis: in laboratory medicine, Dec
prostate cancer research and diagnostics, Dec confronting problems, Nov 704; information 709
735 overload, Oct 640; kitchen behavior, Feb 128; Rounds: continuous ambulatory peritoneal! dialysis-
Prothrombin time (PT): tube filling order's effect on morning behavior, Jan 64; paying full attention associated peritonitis involving Neisseria
specific coagulation parameters in healthy at any given moment, May 320; risk, problem sicca/subflava, June 363; fatal dysrhythmia
subjects, Sept 556 soiving, and individual accountability, March secondary to thyrotoxicosis periodic paralysis,
Pseudohyphae, March 181 192; stress-lowering behaviors, July 448; Oct 614; giant myelolipoma of the adrenal
Pseudomonas aeruginosa: ultraviolet lamp monitor- tantrum-like behavior, Dec 768; teamwork, gland with adenocarcinoma of the colon, Aug
ing in biological safety cabinets with cultures April 256; the way we've always done it, Aug 491; idiopathic eosinophilia associated CMML-
of standard bacterial strains, March 165 512 2 with overexpression of ETV6 gene, Feb 100;
Public health: workforce challenges in public health Reller, L Barth: on blood culture guidelines, Oct 603 lithium self-intoxication treated with
laboratory system, Feb 77. See also Public Renal function tests: as clinical laboratory perspec- hemodialysis, Nov 667; Moraxelia catarrhalis
health laboratories tive on, May 295 pathogenicity, July 420; profound thrombocy-
Public health laboratories: state, surveyed for per- Renin: kidneys’ synthesis of, May 297 topenia associated with administration of epti-
tussis diagnostics, March 169 Reporting: of hepatitis C virus test results, Feb 88 fibatide, Feb 97; radiation necrosis of undeter-
Pulsus paradoxus: in primary effusion lymphoma, Reports: in the electronic medical record, June 339 mined etiology, March 157
March 150 “Reports”: ASCP Board of Registry research RUNX1 (AML1): in study of leukemia genome, Sept
Pyrazinamide: hyperuricemia and arthralgias during 1993-2007, an annotated bibliography, Oct 530
pulmonary tuberculosis therapy with, Aug 495 587; career alternative for phiebotomists in
Pyridinolines: in bone resorption, May 276 forensic toxicology, May 271; chemical terror- Ss
ism, Feb 81; disaster awareness and clinical Saccharomyces cerevisiae: medically-important
Q laboratory students, July 399; laboratory per- yeasts, March 179
“Q&A”: carcinoembryonic antigen test results, Aug spectives on test ordering and interpretation, Safety, patient. See Patient safety
498 July 401; laboratory reports in the electronic Salaries: ASCP Board of Registry research
Q-Probes program (College of American medical record, June 339; laboratory testing
1993-2007, an annotated bibliography, Oct
Pathologists): on benchmark establishment, to identify individuals with inhalant allergies, 591, 592
Dec 709 Nov 649; a “lean” laboratory, March 143:
Quality assurance: American Medical Association molecular diagnostics technologies’ impact on Sampson, Hugh A: on multiallergen tests, Nov 650;
on specific IgE testing, Jan 18
Physician Consortium for Performance reference laboratory testing in large urban
Improvement, Jan 12; CLSI'’s The Key to academic medical center, Aug 472; purchased Satkas, Wanda: in African laboratory training pro-
Quality, June 376; Philip Crosby's absolutes versus rented laboratory instruments, April grams, Feb 68
of, Sept 536; fine art and quality compared, 207; teaching research design and practice in Scheduling: laboratory management at division
June 345; inspections and assessments, Oct MT/CLS curriculum, Oct 582; 2006 annual level, Nov 658
602; on Laboratory instrument survey of medicai laboratory science pro- Schiffgens, Jennifer: on Laboratory Instrument
Implementation, Verification, and Maintenance; grams, Aug 463; workforce challenges in pub- Implementation, Verification, and Maintenance;
Proposed Guideline (GP31-P) in, Dec 715; lic health laboratory system, Feb 77 Proposed Guideline (GP31-P) in, Dec 716
laboratory professionals as uniquely qualified Research: ASCP Board of Registry research Schistocytes: in thrombotic thrombocytopenic pur-
to contribute to, Jan 7; Lean, Jan 6, March 1993-2007, an annotated bibliography, Oct pura/hemolytic uremic syndrome, Oct 610
143, Nov 659; lessons learned from failure, 587; teaching design and practice in MT/CLS Schulze, Matthew: and “pod” laboratories campaign,
April 217; National Medical Laboratory curriculum, Oct 582 Aug 459
Professionals Week on quality, April 199; non- Research!America coalition, May 265 Schwartz formula, May 301
762 LABMEDICINE ® Volume 38 Number 12 # December 2007
labmedicine.com
Annual Index
Science: centrifugation time’s effect on stat clinical Small vessel vasculitides: differential diagnosis of July 431
chemistry testing, March 172; chemilumines- Wegener's granulomatosis from other, July 437 T-cell receptor-Vp ,A ug 478
cent assay for choline analysis in human plas- Smith, Whitney: in African laboratory training pro- TDx-FLM ll, Sept 553
ma and whole blood, Dec 726; communicating grams, Feb 68 Teamwork, April 256
and understanding laboratory test results, Nov Smoking: iron status at birth and maternal, Feb 105 Telomerase: as bladder cancer tumor marker, Feb
680; fetal lung maturity testing in diabetic Sodium: in thyrotoxicosis hypokalemic periodic 118
mothers, Sept 553; hepatoma-specific GGT paralysis, Oct 614 Terminal villous hypoplasia, Oct 627
detection by affinity chromatography, March Somrak, Theresa M: on African laboratory training Terrorism: chemical, Feb 81
160; hospital and clinical laboratory response programs, Feb 68; Cytotechnologist of the Year Test ordering: laboratory perspectives on, July 401;
to mumps exposure, May 285; hyperuricemia award for, Jan 12 requisition errors for blood glucose tests, Sept
and arthralgias during pyrazinamide therapy in South America: Guyana, July 392; laboratory training 559
patients with pulmonary tuberculosis, Aug programs in, Aug 457 Test results: communicating and understanding, Nov
495; immunocomplex substitution reaction in Specimens: of avian influenza A (H5N1) virus, Dec 680
radioimmunoassay of aldosterone, Jan 29; 743; in chemical terrorism preparedness, Feb “Test Your Knowledge”: chemistry, June 375; cyto-
inbound versus outbound diagnoses for sam- 82; pleural effusion sample stability for white genetics, July 443; flow cytometry, Nov 695;
ples submitted for flow cytometric analysis, blood cell and differential counts, Nov 685; for mycology, Dec 749; toxicology, Sept 569
April 240; leukocyte reduction, plasma preventing proficiency testing failures, March Texas: billing legislation in, June 332, Aug 459
apheresis, and cytomegalovirus DNA levels in 185, 186; rejected and unsatisfactory, from Thalassemia: hemoglobin E/S-, Sept 541; hemoglo-
samples, Nov 676; mixing procedures for K2 liquid-based (SurePath) preparations and con- bin H disease and, April 222
EDTA primary samples’ effects on hematologi- ventional Pap smears for cervicovaginal ThinkLab 2007, March 149
cal samples, Dec 723; multiplex antinuclear screening, Dec 729; serum thyroglobulin sta- Thiosulfate-citraie-bile salts-sucrose agar: for Vibrio
antibody assay in pediatric patients, Nov 671; bility for immunoassay, Oct 618. See also cultures, Nov 691
pleural effusions, sample stability for white Blood collection Thoracocentesis: pleural effusion sample stability for
blood cell and differential counts, Nov 685; Sperm counting: comparison of three methods of, white biood cell and differential counts, Nov
“possible” HIV resistance, Jan 26; proficiency April 232 685
testing performance in physician's office, clin- Staffing: ASCP-ASCLS collaboration on, Sept 521; Thrombocythemia: essential, Feb 113
ic, and small hospital laboratories, ASCP Board of Registry research 1993-2007, Thrombocytopenia: in dengue fever, Jan 23; pro-
1994-2004, April 237; rejected and unsatis- an annotated bibliography, Oct 588; strategies found, associated with administration of eptifi-
factory specimens from liquid-based for addressing personnel shortages, June 329, batide, Feb 97; thrombotic thrombocytopenic
(SurePath) preparations and conventional Pap Aug 506(letter); succession planning, May purpura/hemolytic uremic syndrome, Oct 610
smears for cervicovaginal screening, Dec 729; 263; workforce challenges in public health Thrombocytosis: inbound versus outbound diag-
requisition errors for blood glucose tests, Sept laboratory system, Feb 78 noses for leukemia/lymphoma samples sub-
559; serum thyroglobulin stability for Staining: in yeast identification, March 179 mitted for flow cytometric analysis, April 242
immunoassay, Oct 618; sperm-counting metti- Standard deviation index data, March 185 Thrombotic thrombocytopenic purpura/hemolytic
ods compared, April 232; state public health Standardization: in 5Ss practice, Feb 92 uremic syndrome, Oct 610
laboratories surveyed for pertussis diagnos- Standards. See “Lab Guidelines & Standards” Thyroglobulin: serum, stability for immunoassay, Oct
tics, March 169; Torulopsis (Candida) glabrata Staphylococcus aureus: ultraviolet lamp monitoring 618
and Candida krusei identification using calco- in biological safety cabinets with cultures of Thyroid: serum thyroglobulin stability for immunoas-
fluor white, April 227; total and specific IgE in standard bacterial strains, March 165 say, Oct 618; thyrotoxicosis hypokalemic peri-
sera of patients with asthma, urticaria, of Statistics: key terms and their use, Oct 583 odic paralysis, Oct 614
allergic rhinitis, Oct 621; tube filling order's Stat testing: centrifugation time’s effect on clinical Thyrotoxicosis hypokalemic periodic paralysis, Oct
effect on specific coagulation parameters in chemistry testing, March 172 614
healthy subjects, Sept 556; ultraviolet lamp Stem cells: flow cytometry for enumeration of Tissue homogenate-based tests: automation of, July
monitoring in biological safety cabinets with CD34+ stem and progenitor cells, July 433 408
cultures of standard bacterial strains, March Sterchi, Diane: Histotechnologist of the Year award Tissue microarrays: in ribonucleic acid expression
165; 3'UTR polymorphism of IL128B in relation for, Jan 12 profiling, July 409
to susceptibility and development of diabetes, Stoler, Mark: on cytology proficiency-testing regula- Tissue processing: automation and, July 406
May 289; waist circumference and biomarkers tion, June 331 Torulopsis glabrata. See Candida glabrata
for diabetes and cardiovascular disease in Strasinger, Susan: on LabQ, April 204 Towns, Michael: on blood culture guidelines, Oct 603
healthy non-obese women, July 422 Strauss, Pam: on laboratory response to Virginia Toxicology: forensic, May 271; hyperzincuria, Oct
Screening tests: for bladder cancer, Feb 116; for Tech shootings, July 397 608; lithium self-intoxication treated with
cervical cancer, April 198; (-globin gene clus- Stress: behaviors for lowering, July 448 hemodialysis, Nov 667; “Test Your
ter haplotype analysis as predictor of sickle Stropes, Valerie: on Pap testing, April 205 Knowledge,” Sept 569
cell disease severity, Sept 563; rejected and Student learning outcomes, Oct 582 Toyota Production System, Jan 6, March 192
unsatisfactory specimens from liquid-based Student's t-test, Oct 583 Tracer methodology, Jan 8
(SurePath) preparations and conventional Pap Suba, Eric J: on Pap testing, April 205 Training. See Education
smears for cervicovaginal, Dec 729 Succinyicholine: in malignant hyperthermia, Feb 94 Transferrin: in iron transport, Feb 103; as nutritional
Self-directed work teams, April 256 Sulfhemoglobin, Nov 666 status marker, Jan 45
Semen: sperm-counting methods compared, April Supervision: laboratory management at division Transferrin receptor, Feb 103
232 level, Nov 652, 656; NLRB ruling on nurses, Transforming growth factor-(}: autologous platelet
Sepsis: guidelines for testing for, Oct 603 Jan 11; succession planning, May 263 concentrate for production of platelet gel, san
Serology: hepatitis C virus testing, Feb 87 Surface-enhanced laser desorption and ionization 39
Shalkham, John: Cytotechnologist Award for time of flight: for protein profiling, July 410 Transfusion medicine: babesiosis transmitted by,
Outstanding Achievement for, Jan 12 Survivin: as bladder cancer tumor marker, Feb 118 May 283; flow cytometry in, July 434; hepati-
Sialic acid: in influenza, Dec 740 Sutherland, Robert: on H42-A2 guidelines, Nov 661 tis C virus infection, Feb 86; malaria patients
Sickle cell disease: (}-globin gene cluster haplotype Swanbon, Gloria: on JCAHO unannounced surveys, and blood donation, March 153; possible
analysis as predictor of severity of, Sept 563 Jan 8 transfusion reaction with positive direct
Signal to cut-off ratios: in hepatitis C virus testing, T antiglobulin test, Dec 719
Feb 88 Transplantation: flow cytometry in, July 433; kidney,
Simpson, Peggy: on LabQ, April 204 Tabonliong, Beatrix Hannah: on international certifi- May 303
Situation analysis, April 207 cation, June 337 Transthyretin: in amyloidosis, Sept 546
Six Sigma, Jan 6, March 143 Tantrum-like behavior, Dec 768 Trichosporon: medically-important yeasts, March 179
Sjoberg, Stephanie A: Regional Member Award for, Target cells: in hemoglobin E disease, Sept 539 Tube filling order: effect on specific coagulation
May 268 Tartrate-resistant acid phosphatase, May 276 parameters in healthy subjects, Sept 556
Skin-prick test: specific IgE testing compared with, T-cell clonality: flow cytometric assessment of, Aug Tuberculosis: hyperuricemia and arthralgias during
Jan 18, 19 477 pyrazinamide therapy in patients with pul-
Slides. See Digital glass slide technology T-cell proliferation: flew cytometry in assessment of, monary, Aug 495
December 2007 =V olume 38 Number 12@LABMEDICINE 763
labmedicine.cor
g platelet concentrate for production of platelet Wilson, Valerie: on laboratories in Guyana, July 392
re gel, Jan 39 Women’s health: osteoporosis, May 274. See also
or bladder Vasculitides: differential diagnosis of Wegener's Breast cancer; Cervical cancer; Pregnancy
ytology yranulomatosis from other small vessel, July Wood, Jane Pine, Aug 459
2-based mark 437 Woodcock, Sheila: on nonconforming laboratory
cil Vibrio: in the United States, Nov 688 event management, Sept 537
Vibrio cholerae, Nov 688 Workarounds, Nov 659
yn stat Vibrio parahaemolyticus, Nov 688 Workplace: ASCP Board of Registry research
ot Vibrio vulnificus, Nov 688 1993-2007, an annotated bibliography, Oct
Vircinia Tech shootings, July 39( 987: conflict resolution in, March 145
Virology: avian influenza A (H5N1), Dec 740; hepati World Wide Web (WWW): eCourses, Feb 75, March
rative tis C virus, Feb 85; hospital and clinical labo 149: Labs Are Vital Web site, May 266
ratory response to mumps exposure, May Medscape, June 334
285; human papillomavirus as etiologic agent Wound healing: autologous platelet concentrate for
of cervical cancer, May 260, 269; primary production of platelet gel, Jan 39
effusion lymphoma associated with human
herpesvirus-8, March 150
gica Virtual phenotype: “possible” HIV resistance, Jan 26 X-ray absorptiometry, dual-energy: for bone healtt
rd ba Volunteering, Aug 454 oan
assessment, May 275, 277
Von Willebrand disease: and hemophilia B, April 218
62 Von Willebrand factor: in thrombotic thrombocy
) topenic purpura/hemolytic uremic syndrome Yadrandji, Soheila: on laboratory response
ict 617 T1 er hy cctt yotings, July 397
Yeasts: medically-important, March 178; “Test Your
W Knowledge,” Dec 749: Torulopsis (Candida
Wages. See Salaries glabrata ar } Candida krusei \dentificatior
A
t Waist circumference: and biomarkers for diabetes SING Ca ofluor white, April 22
} ind Cardiovascular disease in healthy nor
i pese womer! JUTY 427
wy f Walsh-Feeks, Anne: joins LABMEDICINE Editoria Zaleski, M Sue: ASCP Member Excellence in
testing Advisory Board, Nov 64¢€ Management Award for, March 136
t Wegener's granulomatosis: differential diagnosis Zert defects standard Ser t 52°F
ased from other small vessel vasculitides, July 43 Zinc: hyperzincuria, Oct 608
i Weinstein, Melvin P: on blood culture guidelines, Oct 4 ygomycIevteeest:e s in npaatiteinte ntw wiitthh csyycstteemni c lupr us eorryyttth e
604 Y atosus, AuAg )4 87 7
We Ron: leaves LABMEDICINE Editorial Advisory
Board, Nov 64¢€
ent West an: on phiebotomists, March 140
WH M y dr ¢ Se ot ’
White blood cell (WBC) count: pleural ef sample
y J tability for differential counts and, Nov 685
Whitley, Susan: on CLSI’s The Key to Ot ity y, June 376
Whooping cough. See Pertuss
Wied. George: in automat f yyne iOGIc Cytology
May 269
W Michae blow jlture quidelines. Oct
s December 2007